Becker's Healthcare January 15, 2025
Patsy Newitt

Walgreens Boots Alliance reported a $245 million operating loss in 2025’s first fiscal quarters, the three months ending Nov. 30.

Here are 10 things for ASCs to know:

1. The $245 million operating loss marks a significant rise from the $39 million operating loss recorded in the same quarter last year.

2. “Our first quarter results reflect our disciplined execution against our 2025 priorities: stabilizing the retail pharmacy by optimizing our footprint, controlling operating costs, improving cash flow and continuing to address reimbursement models,” CEO Tim Wentworth said in a Jan. 10 news release. “While our turnaround will take time, our early progress reinforces our belief in a sustainable, retail pharmacy-led operating model.”

3. According to the release, higher...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: ASC, Pharma, Pharma / Biotech, Provider
Walgreens PE deal back on the table: 5 things to know
Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more
Pharma Pulse 2/20/25: Popping the Gross-to-Net Bubble, Prompting Better Care with Question Prompt Lists & more
AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M Deal
The Unique Challenges, Growth in the Business of Health-System Pharmacy

Share This Article